POB3 EVALUATION OF THE COST-UTILITY OF ORLISTAT (XENICAL) IN THE UNITED KINGDOM
Nov 1, 2004, 00:00 AM
10.1016/S1098-3015(10)65900-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)65900-1/fulltext
Section Title :
Section Order :
268
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65900-1&doi=10.1016/S1098-3015(10)65900-1